Artemisia annua Nanofibers for Advanced Wound Care

Introduction

Wound dressing development demands materials that support healing while preventing infection.

Recent biomaterial research has explored how botanical extracts might be integrated into advanced delivery systems for topical applications. Artemisia annua, a plant traditionally recognized for antimalarial compounds, contains a variety of secondary metabolites that show signs of antimicrobial and calming activity in laboratory studies.

A 2020 study published in Progress in Biomaterials investigated an electrospun nanofiber system combining Artemisia annua methanol extract with gelatin—marking the first reported use of this plant in a nanofibrous wound dressing format. Researchers fabricated a double-layer structure, characterized its chemical and mechanical properties, and evaluated its performance in cell culture and bacterial assays.

This article examines the material design, fabrication approach, and laboratory findings—offering R&D professionals insight into how botanical extracts can be engineered into structured biomaterials for potential topical applications.

Key Takeaways

• Artemisia annua methanol extract was successfully integrated into gelatin nanofibers via electrospinning, with ATR-FTIR analysis confirming the presence of functional groups including peroxide moieties.
• The electrospun gelatin/Artemisia annua nanofibers had a mean diameter of 242.00 ± 67.53 nm and required crosslinking to maintain structural stability in aqueous environments.
• Crosslinked samples demonstrated sustained release of Artemisia annua compounds over 7 days in vitro, suggesting potential for extended-duration topical delivery systems.
• In cell culture studies, fibroblasts seeded on the material showed good proliferation and attachment, with no cytotoxic effects observed.
• The fabricated dressings showed antibacterial activity against Staphylococcus aureus in laboratory assays, though the study did not quantify potency or compare to clinical standards.
• This was a materials characterization study—findings relate to laboratory performance only and do not predict clinical wound healing outcomes.

What the Research Examined

The research team collected Artemisia annua plant material from the Gorgan forest area in Northern Iran and prepared a methanol extract for incorporation into wound dressing materials.

Researchers designed a two-layer nanofiber structure. The top layer combined gelatin (as the structural polymer) with Artemisia annua extract, fabricated using electrospinning—a technique that uses electrical force to draw polymer solutions into ultrafine fibers. The bottom layer consisted of polycaprolactone (PCL), a synthetic polymer known for mechanical strength and slower degradation rates.

This dual-layer approach aimed to balance biological activity from the botanical extract with mechanical stability from the PCL base. After fabrication, samples underwent chemical crosslinking with glutaraldehyde vapor to improve structural integrity when exposed to moisture.

The team characterized the materials using multiple analytical techniques: ATR-FTIR spectroscopy for chemical composition, scanning electron microscopy (SEM) for fiber morphology, and mechanical testing for tensile properties. They then evaluated in vitro extract release kinetics in phosphate-buffered saline (PBS) and assessed structural stability over time in aqueous conditions.

Biological evaluation included fibroblast cell culture studies to assess biocompatibility and proliferation, along with disc diffusion assays against Staphylococcus aureus to test antibacterial properties.

Key Findings from Materials Characterization

ATR-FTIR analysis confirmed that the electrospinning process successfully incorporated Artemisia annua compounds into the nanofiber matrix. Researchers detected characteristic functional groups associated with the plant extract, particularly peroxide groups (around 880 cm⁻¹) and other aromatic compounds.

SEM imaging revealed that the gelatin/Artemisia annua fibers formed a uniform nanofibrous structure with an average diameter of 242.00 ± 67.53 nm. The researchers noted that increasing extract concentration did not significantly alter fiber morphology, suggesting the electrospinning parameters were robust across the tested formulations.

Mechanical testing indicated that crosslinking slightly reduced the tensile properties compared with the uncrosslinked samples. However, the materials still maintained mechanical characteristics considered suitable for wound dressing applications. In this multilayer design, the PCL base layer provided most of the structural strength, while the gelatin–Artemisia annua layer functioned primarily as the bioactive interface, supporting sustained release of the plant extract and biological activity.

Release studies demonstrated that non-crosslinked samples rapidly released incorporated compounds, while crosslinked versions achieved sustained release over 7 days. This extended release profile is particularly relevant for topical applications where prolonged contact with bioactive compounds may be desirable.

Structural stability testing in PBS showed that crosslinked samples maintained their fibrous architecture over the study period, while non-crosslinked controls degraded quickly. This finding underscores the importance of crosslinking for materials intended for moist wound environments.

Biological Performance in Laboratory Models

Fibroblast cell culture studies revealed that cells attached to and proliferated on the Artemisia annua-containing nanofibers. SEM images showed fibroblasts spreading across the fiber surface with visible pseudopodia formation—morphological indicators of cell adhesion.

Quantitative cell viability assays detected no cytotoxic effects from the incorporated plant extract at the concentrations tested. Cell proliferation appeared comparable to control materials, suggesting the fabrication process did not create compounds harmful to mammalian cells at these exposure levels.

The research team noted this is significant because electrospinning involves organic solvents and crosslinking introduces reactive aldehydes—processes that could potentially generate cytotoxic residues if not properly controlled.

Disc diffusion tests showed antibacterial activity against Staphylococcus aureus. The crosslinked Artemisia annua dressing produced an inhibition zone of about 5.0 ± 0.2 mm, while the control material showed none. Gentamicin served as a positive control. However, the study did not compare the results with commercial wound dressings or other microbial species.

Researchers attributed the antibacterial properties to bioactive compounds in the Artemisia annua extract, citing previous literature documenting antimicrobial activity of this plant's metabolites. However, the study did not isolate specific compounds responsible for the observed effects or determine which remained active after electrospinning.

What This Means for Biomaterial Formulators

This research demonstrates a fabrication pathway for incorporating botanical extracts into structured nanofiber systems—relevant for formulators exploring plant-derived actives in topical biomaterials.

The electrospinning approach offers several technical advantages for extract delivery. The high surface-area-to-volume ratio of nanofibers maximizes extract exposure at the material-tissue interface. The ability to control release kinetics through crosslinking density provides formulation flexibility for different application requirements.

From a sourcing perspective, the study used methanol extraction—a common industrial process. Formulators considering similar approaches should note that extraction solvent choice affects which plant compounds are recovered and may influence final material properties and regulatory classification.

The two-layer design strategy addresses a practical challenge in bioactive material development: balancing biological function with mechanical performance. The gelatin layer provides a hydrophilic, cell-compatible surface for extract delivery, while the PCL base supplies structural support. This modular approach could be adapted for other botanical actives with similar solubility and stability profiles.

For R&D teams, the ATR-FTIR detection of peroxide groups is noteworthy. These functional groups are associated with some of Artemisia annua's documented biological activities in other studies. However, peroxides can also present stability challenges in finished products, particularly during storage and sterilization. Material developers would need to assess peroxide content stability over product shelf life.

The crosslinking requirement introduces formulation considerations. Glutaraldehyde vapor treatment improved structural stability but adds a processing step and requires validation that residual crosslinker levels are biocompatible. Alternative crosslinking methods (e.g., genipin, EDC/NHS chemistry) might offer different performance or regulatory profiles.

Limitations and What We Don't Know Yet

This study provides materials characterization and preliminary biological screening but does not address several factors critical for clinical translation.

Most significantly, all testing was conducted in laboratory models. The research included no animal wound healing studies, no human clinical data, and no comparison to commercial wound dressing standards. Whether these materials would actually support healing in living tissue remains unknown.

The antibacterial testing was limited to a single bacterial strain (Staphylococcus aureus) using qualitative disc diffusion methods. Real wound infections often involve multiple bacterial species, biofilm formation, and resistant organisms. The study did not assess activity against gram-negative bacteria, fungi, or clinically relevant resistant strains like MRSA.

Researchers did not identify which specific compounds from Artemisia annua were incorporated into the fibers, what concentrations were achieved, or how extraction and processing affected compound stability. This makes it difficult to relate findings to other Artemisia annua research or to establish quality specifications for material reproduction.

The release study measured total extract release but did not quantify individual bioactive compounds or assess whether released materials retained biological activity. Electrospinning involves high voltage and rapid solvent evaporation, which could denature sensitive molecules.

Mechanical testing provided basic tensile data but did not evaluate properties most relevant to wound dressings: conformability to irregular surfaces, moisture vapor transmission rate, exudate absorption capacity, or ease of removal without tissue disruption.

The fibroblast studies showed compatibility but did not investigate other cell types involved in wound healing (keratinocytes, endothelial cells, immune cells) or examine whether the material influences healing processes like re-epithelialization, angiogenesis, or collagen remodeling.

From a regulatory perspective, botanical extracts present complex challenges. The study did not address batch-to-batch variability in plant material, standardization approaches, or how geographical/seasonal variation might affect extract composition and material performance.

Finally, this was a single exploratory study from one research group. Independent replication and optimization would be necessary to establish the reproducibility and scalability of this approach.

Frequently Asked Questions

What is electrospinning and why was it used for this wound dressing?

Electrospinning is a fabrication technique that uses electrical force to draw polymer solutions into ultrafine fibers, typically in the nanometer to micrometer range. For wound dressings, this creates high surface area structures that can mimic aspects of natural extracellular matrix architecture while enabling controlled delivery of incorporated compounds.

What bioactive compounds does Artemisia annua contain?

Artemisia annua produces numerous secondary metabolites including artemisinin (known for antimalarial properties), flavonoids, coumarins, and various terpenes. This particular study used methanol extraction, which would recover a mix of these compounds, though the research did not quantify specific constituents in the final material.

How does crosslinking affect the nanofiber structure?

Crosslinking creates chemical bonds between gelatin polymer chains, improving mechanical strength and resistance to dissolution in aqueous environments. In this study, glutaraldehyde vapor treatment enabled the gelatin/Artemisia annua layer to maintain structural integrity in moisture, though it also slowed the release rate of incorporated botanical compounds.

Why was a two-layer structure used instead of a single material?

The researchers designed a bilayer system to address competing requirements: the gelatin top layer provides hydrophilicity and bioactivity delivery, while the PCL base layer supplies mechanical support and slower degradation. This modular approach allows optimization of each layer for specific functions.

What does sustained release mean in this context?

Sustained release refers to the gradual, controlled release of incorporated compounds over time rather than rapid, immediate release. The crosslinked samples in this study released Artemisia annua extract components progressively over 7 days in laboratory testing, potentially extending the duration of biological activity.

What is Staphylococcus aureus and why was it tested?

Staphylococcus aureus is a gram-positive bacterium commonly found in wound infections. It's frequently used as a test organism in antimicrobial studies because it's clinically relevant and represents one class of bacteria that wound dressings may need to control.

Can this material be sterilized for medical use?

The study did not evaluate sterilization methods. This is a significant gap, as medical devices require validated sterilization processes. Common methods (gamma irradiation, ethylene oxide, autoclaving) could potentially affect both the polymer structure and the botanical compounds' activity.

How does this compare to commercial wound dressings?

The research did not include comparisons to commercial products. While the material showed promising laboratory properties, direct performance benchmarking against established wound care products would be necessary to assess competitive positioning and clinical utility.

Research Summary

• Research focus: Development and characterization of electrospun gelatin/Artemisia annua nanofiber wound dressings with a PCL support layer
• Study type: Materials science study combining chemical characterization, in vitro release testing, cell culture biocompatibility assessment, and bacterial disc diffusion assays
• Key findings: Successfully fabricated nanofibers (242 nm average diameter) with detectable Artemisia annua functional groups; crosslinked versions showed sustained release over 7 days, maintained structural stability in aqueous environments, supported fibroblast proliferation without cytotoxicity, and demonstrated antibacterial activity against S. aureus
• Key limitations: No animal or human testing; single bacterial strain evaluated; specific bioactive compounds not identified or quantified; no comparison to commercial standards; no investigation of actual wound healing processes; sterilization compatibility unknown; reproducibility and scalability not established
• Professional applications: Demonstrates technical feasibility of incorporating botanical extracts into electrospun nanofiber delivery systems; provides fabrication parameters for formulators exploring similar approaches; illustrates dual-layer design strategy for balancing biological activity with mechanical performance in topical biomaterials

‍

For Professionals: Quick Reference

• Extract preparation: Methanol extraction of Artemisia annua aerial parts
• Fabrication method: Electrospinning; gelatin concentration and voltage parameters critical for fiber formation
• Crosslinking: Glutaraldehyde vapor treatment necessary for aqueous stability; duration affects release kinetics
• Testing considerations: ATR-FTIR confirms botanical integration; SEM for fiber morphology; consider compound stability analysis
• Regulatory note: Botanical extracts add complexity to device classification and batch consistency requirements

This article is based on published scientific research.

Content reviewed for scientific accuracy.

Last updated: 12/3 - 2026